Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (26738)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2020 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hanafy AS, Abd-Elsalam S. Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective. World J Gastroenterol 2020; 26(46): 7272-7286 [PMID: 33362383 DOI: 10.3748/wjg.v26.i46.7272] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i46/7272.htm |
| Number | Citing Articles |
| 1 |
Takumi Umemura, Kazuki Nishikawa, Yoshikazu Mutoh, Hajime Sasano, Koji Kozaki, Tetsuya Yamada, Toshihiko Ichihara. Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child–Pugh class C. Journal of Antimicrobial Chemotherapy 2021; 76(7): 1947 doi: 10.1093/jac/dkab076
|
| 2 |
M. Vitrone, F. Mele, E. Durante-Mangoni, R. Zampino. Drugs and liver injury: a not to be overlooked binomial in COVID-19. Journal of Chemotherapy 2022; 34(4): 207 doi: 10.1080/1120009X.2021.1988203
|
| 3 |
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practice. World Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
|
| 4 |
Mohammed Hussien Ahmed, Hebat Allah Abdel Maksoud Ahmed, Nahla Abd el-Aziz Nosair, Asmaa Mbarak Hassan, Dalia ElSayed Sherief, Aya Mohammed Mahros. Fecal Calprotectin as a Predictor of COVID-19 Severity. Journal of Coloproctology 2021; 41(04): 361 doi: 10.1055/s-0041-1736646
|
| 5 |
George D Panayiotakopoulos, Dimitrios T Papadimitriou. Rifampicin for COVID-19. World Journal of Virology 2022; 11(2): 90-97 doi: 10.5501/wjv.v11.i2.90
|
| 6 |
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng. COVID‐19‐associated liver injury: Adding fuel to the flame. Cell Biochemistry and Function 2023; 41(8): 1076 doi: 10.1002/cbf.3883
|
| 7 |
Camila Araújo Miranda, João Rodolfo Domingues Mansano, Fábio Erminio Mingatto. Ivermectin-induced toxicity in HepG2 cells and the protective effect of tetrahydrocurcumin and vitamin C. Drug and Chemical Toxicology 2024; : 1 doi: 10.1080/01480545.2024.2389954
|
| 8 |
Faisal Inayat, Hassam Ali, Pratik Patel, Rubaid Dhillon, Arslan Afzal, Attiq Ur Rehman, Muhammad Sohaib Afzal, Laraib Zulfiqar, Gul Nawaz, Muhammad Hassan Naeem Goraya, Subanandhini Subramanium, Saurabh Agrawal, Sanjaya K Satapathy. Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States. World Journal of Virology 2023; 12(4): 221-232 doi: 10.5501/wjv.v12.i4.221
Abstract(668) |
Core Tip(718) |
Full Article(HTML)(2248)
|
Full Article with Cover (PDF)-832K(100)
|
Full Article (Word)-285K(54)
|
Audio-2466K(4)
|
Peer-Review Report-203K(71)
|
Answering Reviewers-141K(78)
|
Supplementary Material-84K(82)
|
Full Article (PDF)-635K(147)
|
Full Article (XML)-150K(90)
|
Times Cited (3)
|
Total Visits (7591)
|
Open
|
| 9 |
Gholam Reza Sivandzadeh, Hassan Askari, Ali Reza Safarpour, Fardad Ejtehadi, Ehsan Raeis-Abdollahi, Armaghan Vaez Lari, Mohammad Foad Abazari, Firoozeh Tarkesh, Kamran Bagheri Lankarani. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World Journal of Clinical Cases 2021; 9(22): 6178-6200 doi: 10.12998/wjcc.v9.i22.6178
|
| 10 |
Roya Mahdavi, Zahra Akbari Jonoush, Mehri Ghafourian, Seyed Esmaeil Khoshnam, Fereshteh Nezhad Dehbashi, Maryam Farzaneh. The Effect of Remdesivir as an anti-COVID-19 Drug on Chicken Hepatocyte Enzymes; an in vitro Study. Iranian Journal of Medical Microbiology 2023; 17(3): 309 doi: 10.30699/ijmm.17.3.309
|
| 11 |
Wen-Zheng Yuan, Tao Fu. Liver Dysfunction in COVID-19: From Onset to Recovery. Seminars in Liver Disease 2022; 42(02): 151 doi: 10.1055/s-0042-1745871
|
| 12 |
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?. World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
|
| 13 |
Kimia Kardani, Azam Bolhassani, Mona Kardani, Elnaz Agi. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. Journal of Medical Microbiology and Infectious Diseases 2021; 9(3): 122 doi: 10.52547/JoMMID.9.3.122
|